Catalyst Wire Dossier Catalyst Wire Dossier

Tranylcypromine

tranylcypromine · Par Pharmaceutical, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Tranylcypromine, covering 2008-04-04 to 2022-06-27. Get the full timeline:

Most recent: FDA Approved: TRANYLCYPROMINE — Original Application (Solco Healthcare US, LLC)

See pricing